Positive mid-stage results for Medicago and GSK’s plant-derived COVID-19 vaccine
Plant-derived vaccine candidate showed promising antibody responses against COVID-19 in Phase II study
Read More
Tag: Medicago
GSK, Medicago launch late-stage trial of plant-derived COVID-19 vaccine
Vaccine candidate has previously been granted FDA fast track designation
Read More
GSK links with Medicago to develop novel COVID-19 vaccine
Phase I clinical testing scheduled to begin mid-July
Read More
- Storm Therapeutics and AlidaBio launch collaboration to advance RNA‑targeting cancer therapies
- Excellence adventure
- MHRA approves Nucala for eosinophilic COPD in adults on triple therapy
- Bial launches new sublingual Parkinson’s treatment in UK
- Acesion Pharma launches phase 2 trial of AP31969 in atrial fibrillation
